Aclaris Therapeutics, Inc.
Clinical trials sponsored by Aclaris Therapeutics, Inc., explained in plain language.
-
New eczema drug shows promise in early trial
Symptom relief CompletedThis study tested an experimental drug called ATI-2138 in 14 adults with moderate to severe atopic dermatitis (eczema). Participants took the drug for 12 weeks to see if it was safe and could improve their skin symptoms. The main goal was to check for side effects, while also mea…
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Symptom relief
Last updated May 17, 2026 03:43 UTC
-
New drug shows promise for painful skin condition
Symptom relief CompletedThis study tested an experimental drug called ATI-450 in 95 people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. Participants received either ATI-450 or a placebo for 12 weeks. The main goal was to see if the drug…
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Symptom relief
Last updated May 06, 2026 16:14 UTC